United States · Who invested in CaroGen?
CaroGen's investors include National Institutes of Health, Connecticut Innovations, Bijan Almassian, Marc Silver and Valerian Nakaar.
201320152017201920212023
$150KSeed$6.8MGrant
United States · Funded startup
Who invested in CaroGen
Funding summaryUpdated 26 Oct 2026
$7.0Mraised across 2 rounds since 2013, from 2 sources
$150KSeed$6.8MGrant
- Latest round
- Grant, $6.8MDec 2023
- Step-upi
- 45.3×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $150K Sept 2013
- Biggest round
- $6.8M Grant · Dec 2023
- Between rounds
- 10.3 years from the last two
The rounds
- Dec 2023
- Sept 2013
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Seed2013Grant2023
National Institutes of Health
Connecticut InnovationsBijan AlmassianMarc SilverValerian Nakaar
National Institutes of HealthConnecticut InnovationsBijan AlmassianMarc SilverValerian NakaarEveryone who backed them
Bijan Almassianno record of our own yet1round
Marc Silverno record of our own yet1round
Valerian Nakaarno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about CaroGen
How much has CaroGen raised?
CaroGen has raised $7.0M across 2 rounds since 2013.
When did CaroGen last raise?
CaroGen's most recent round was a Grant of $6.8M in Dec 2023.
What was CaroGen's biggest round?
Its most recent round, $6.8M in Dec 2023, is also its largest on record.
Who backed CaroGen first?
CaroGen's first round on record, in Sept 2013, was backed by Bijan Almassian, Marc Silver and Valerian Nakaar.
What stage is CaroGen at?
CaroGen's latest named round is a Grant, in Dec 2023.
Where is CaroGen based?
CaroGen is based in the United States.
Companies like CaroGen
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.